Her early research career was supported through the EDCTP1- and EDCTP2-funded PanACEA consortium, aimed at accelerating the development of shorter TB treatment regimens and developing a sustainable TB clinical trials network in Africa.
She later received an EDCTP2 Senior Fellowship to investigate ways to reduce the side effects of TB medicines while training doctoral and master’s students in Tanzania. She is now the principal investigator of the OptiRiMoxTB trial, part of the EDCTP2-funded SimpliciTB project, which is evaluating a shortened TB treatment regimen.
Dr Mpagama also co-leads the Global Infectious Diseases Research Programme, a joint initiative between the Kilimanjaro Clinical Research Institute (KCRI), Tanzania, and the University of Virginia, USA, which is providing tailored training to six postdoctoral researchers from Tanzania, supporting their development as future research leaders.
Discover more EDCTP-supported global health leaders
Professor Abdoulaye Djimdé is one of Africa’s leading experts on malaria genomics and antimalarial drug resistance.
Dr Christian Happi is a molecular biologist and genomic scientist internationally recognised for his work on infectious disease surveillance.
Dr Cissy Kityo is a physician and HIV researcher who played a pioneering role in introducing and scaling up antiretroviral therapy in Uganda.
Dr Delese Mimi Darko is a leading figure in medicines regulation in Africa.
Professor Marieke van der Zalm is a paediatric clinical researcher and one of the world’s leading experts on the long-term impact of tuberculosis (TB) on children’s lung health.
Dr Nicaise Ndembi is a renowned virologist and global health leader working at the intersection of science and policy.
Professor Pauline Byakika is a physician and infectious disease specialist whose research focuses on malaria treatment and the interactions between antimalarial and antiretroviral medicines.
Professor Salim Abdool Karim is one of Africa’s most prominent infectious disease epidemiologists.
Dr Stellah Mpagama is a leading tuberculosis (TB) researcher whose work focuses on improving TB treatment and understanding how other conditions, such as diabetes, affect TB outcomes.
Professor Tulio de Oliveira is a bioinformatician and global leader in genomic surveillance of infectious diseases.